Synaero™ Hemostatic Gel represents the next step in ENT surgical hemostasis, introducing a surface-acting hemostatic gel that controls bleeding and maintains a patent airway after surgery. The gel, developed in conjunction and distributed by ENTrigue Surgical Inc., contains HemCon’s proprietary formulation of oxidized cellulose, a material with proven history of hemostatic capabilities. Application onto nasal mucosa provides hemostasis without the need for packing, giving surgeons clear visibility of the surgical field, allowing for more precise and faster procedures, as well as increased patient comfort.